Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment

Fibroblast growth factor receptor 3 (FGFR3) alters frequently across various cancer types and is a common therapeutic target in bladder urothelial carcinoma (BLCA) with FGFR3 variants. Although emerging evidence supports the role of FGFR3 in individual cancer types, no pan-cancer analysis is availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Juanni, Hu, Kuan, Huang, Jinzhou, Zhou, Lei, Yan, Yuanliang, Xu, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266346/
https://www.ncbi.nlm.nih.gov/pubmed/34160364
http://dx.doi.org/10.18632/aging.203175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266346/
https://www.ncbi.nlm.nih.gov/pubmed/34160364
http://dx.doi.org/10.18632/aging.203175

Ejemplares similares